Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARDINAL HEALTH INCCAH · Entity 3014 | Chief Executive Officer | August 18, 2026 | August 20, 2026 |
| DAVITA INC.DVA · Entity 3482 | Director | August 15, 2026 | August 18, 2026 |
| SEARS HOLDINGS CORPSHLD · Entity 157643 | Chief Financial Officer | October 14, 2016 | October 21, 2016 |
| TENNECO INCTEN · Entity 11746 | Exec. Vice President and CFO | March 04, 2020 | March 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARDINAL HEALTH INC
Report date August 18, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 190,603 |
Ending reported balance
After 2026-08-19 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2026-08-18 · Sale · Disposed 21,407 · Balance 293,725 F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4. Row 2 · 2026-08-18 · Sale · Disposed 29,915 · Balance 263,810 F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive. Row 3 · 2026-08-18 · Sale · Disposed 16,208 · Balance 247,602 F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive. Row 4 · 2026-08-18 · Sale · Disposed 12,470 · Balance 235,132 F4: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive. Row 5 · 2026-08-19 · Sale · Disposed 6,206 · Balance 228,926 F5: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive. Row 6 · 2026-08-19 · Sale · Disposed 3,457 · Balance 225,469 F6: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive. Row 7 · 2026-08-19 · Sale · Disposed 5,704 · Balance 219,765 F7: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive. Row 8 · 2026-08-19 · Sale · Disposed 6,731 · Balance 213,034 F8: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive. Row 9 · 2026-08-19 · Sale · Disposed 16,187 · Balance 196,847 F9: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive. Row 10 · 2026-08-19 · Sale · Disposed 6,244 · Balance 190,603 F10: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive.
F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive.
F4: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive.
F5: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive.
F6: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive.
F7: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive.
F8: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive.
F9: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive.
F10: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive.
DAVITA INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,883 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Grant · Acquired 278 · Balance 6,883 |
SEARS HOLDINGS CORP
Report date October 14, 2016 · Filed October 21, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2016-10-14 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
TENNECO INC
Report date March 04, 2020 · Filed March 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 43,599 |
Reported balance
After 2020-03-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-03-04 · Grant · Acquired 43,599 · Balance 43,599 F2: Reflects restricted stock units granted to the Reporting Person pursuant to Section 16b-3, one third of which vest on each of the first three anniversaries of the grant date. Each restricted stock unit represents the contingent right to receive one share of Class A Common Stock. F3: Does not give effect to 42,720 restricted stock units previously granted to the Reporting Person and which vest on different schedules. |
| Cash-Settled Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,475 |
Reported balance
After 2020-03-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-03-04 · Grant · Acquired 23,475 · Balance 23,475 F4: Reflects cash-settled restricted stock units granted to the Reporting Person pursuant to Section 16b-3, one third of which vest on each of the first three anniversaries of the grant date. Each restricted stock unit represents the contingent right to receive the fair market value of one share of Class A Common Stock on the vesting date. |
| Class A Common StockSEC Table I · non-derivative | Direct | 73,480 |
Reported balance
Holding disclosure · report date 2020-03-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 73,480 |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,781 |
Reported balance
Holding disclosure · report date 2020-03-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,781 F1: Reflects restricted stock granted to the Reporting Person pursuant to Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock granted to the Reporting Person pursuant to Rule 16b-3.
F2: Reflects restricted stock units granted to the Reporting Person pursuant to Section 16b-3, one third of which vest on each of the first three anniversaries of the grant date. Each restricted stock unit represents the contingent right to receive one share of Class A Common Stock.
F3: Does not give effect to 42,720 restricted stock units previously granted to the Reporting Person and which vest on different schedules.
F4: Reflects cash-settled restricted stock units granted to the Reporting Person pursuant to Section 16b-3, one third of which vest on each of the first three anniversaries of the grant date. Each restricted stock unit represents the contingent right to receive the fair market value of one share of Class A Common Stock on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,244 | $237.88 | $1,485,322.72 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 10 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,603 F10 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 16,187 | $237.23 | $3,840,042.01 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 9 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,847 F9 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,731 | $236.46 | $1,591,612.26 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 8 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,034 F8 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 5,704 | $235.34 | $1,342,379.36 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 7 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,765 F7 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 3,457 | $234.29 | $809,940.53 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 6 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,469 F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,206 | $233.22 | $1,447,363.32 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 5 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,926 F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 12,470 | $237.25 | $2,958,507.50 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 4 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,132 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 16,208 | $236.54 | $3,833,840.32 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 3 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,602 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 29,915 | $235.51 | $7,045,281.65 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,810 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 11:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 21,407 | $234.56 | $5,021,225.92 |
DisclosureSEC source: 0001687858-26-000003 · wk-form4_1787225611.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,725 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 103,449 | $235.17 | $24,328,101.33 |
DisclosureSEC source: 0001687858-26-000002 · wk-form4_1787083959.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,132 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 48,021 RSUs and 187,965 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 20:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 30,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001687858-26-000002 · wk-form4_1787083959.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,581 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2027. Read SEC document |
| August 15, 2026 Filed Aug 18, 2026 22:10 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000124 · wk-form4_1787091048.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,883 Read SEC document |
| August 04, 2026 Filed Aug 6, 2026 10:02 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 187,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-26-000027 · wk-form4_1786010529.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 387,965 F1 · kind: Reflects performance share units that will settle on August 15, 2026. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:11 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000078 · wk-form4_1779135073.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,605 Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:09 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-26-000040 · wk-form4_1773778172.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,355 Read SEC document |
| November 15, 2025 Filed Nov 17, 2025 23:46 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000176 · wk-form4_1763423158.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,023 Read SEC document |
| August 20, 2025 Filed Aug 20, 2025 20:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 22,957 | $150.40 | $3,452,732.80 |
DisclosureSEC source: 0000721371-25-000100 · wk-form4_1755720724.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.94 to $150.80, inclusive. Read SEC document |
| August 20, 2025 Filed Aug 20, 2025 20:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 12,944 | $149.40 | $1,933,833.60 |
DisclosureSEC source: 0000721371-25-000100 · wk-form4_1755720724.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,957 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.85, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4. Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 23:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,313 | $149.45 | $943,477.85 |
DisclosureSEC source: 0000721371-25-000095 · wk-form4_1755645580.xml · nonDerivative · entry 5 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,901 F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.58, inclusive. Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 23:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 94,735 | $148.92 | $14,107,936.20 |
DisclosureSEC source: 0000721371-25-000095 · wk-form4_1755645580.xml · nonDerivative · entry 4 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,214 F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.40 to $149.39, inclusive. Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 23:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 6,657 | $148.15 | $986,234.55 |
DisclosureSEC source: 0000721371-25-000095 · wk-form4_1755645580.xml · nonDerivative · entry 3 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,949 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.40 to $148.39, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4, 5, and 6 to this Form 4. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 23:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 136,407 | $150.22 | $20,491,059.54 |
DisclosureSEC source: 0000721371-25-000095 · wk-form4_1755645580.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,606 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 61,869 RSUs and 245,420 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 23:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 42,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-25-000095 · wk-form4_1755645580.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,013 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2026. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 21:22 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000148 · wk-form4_1755638525.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,612 Read SEC document |
| August 12, 2025 Filed Aug 12, 2025 20:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 245,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-25-000083 · wk-form4_1755029652.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,235 F1 · kind: Reflects performance share units that will settle on August 15, 2025. Read SEC document |
| June 30, 2025 Filed Jun 30, 2025 20:16 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 5,821 | $167.18 | $973,154.78 |
DisclosureSEC source: 0000721371-25-000063 · wk-form4_1751314609.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,815 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the deferred settlement of performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| May 15, 2025 Filed May 17, 2025 01:14 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 348 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000099 · wk-form4_1747444447.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,243 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 23:42 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 349 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-25-000064 · wk-form4_1742341315.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,895 Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:25 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000198 · wk-form4_1732051528.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,546 Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 00:24 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 46,455 | $109.02 | $5,064,524.10 |
DisclosureSEC source: 0000721371-24-000081 · wk-form4_1724113487.xml · nonDerivative · entry 5 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,636 F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.70 to $109.32, inclusive. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 00:24 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 26,716 | $108.87 | $2,908,570.92 |
DisclosureSEC source: 0000721371-24-000081 · wk-form4_1724113487.xml · nonDerivative · entry 4 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,091 F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.58 to $109.14, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 00:24 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 7,875 | $107.91 | $849,791.25 |
DisclosureSEC source: 0000721371-24-000081 · wk-form4_1724113487.xml · nonDerivative · entry 3 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,807 F4 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 17,699 RSUs. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:24 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 48,188 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-24-000081 · wk-form4_1724113487.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,682 F3 · kind: Grant of restricted share units that vest in three equal annual installments beginning on August 15, 2025. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:24 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 30,275 | $106.36 | $3,220,049.00 |
DisclosureSEC source: 0000721371-24-000081 · wk-form4_1724113487.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,494 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 35,200 restricted share units ("RSUs") and 45,958 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 22:23 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000141 · wk-form4_1724106186.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,234 Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:15 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 45,958 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-24-000065 · wk-form4_1723666522.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,769 F1 · kind: Reflects performance share units that will settle on August 15, 2024. Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:30 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000109 · wk-form4_1715981407.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,901 Read SEC document |
| March 15, 2024 Filed Mar 20, 2024 00:27 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-24-000058 · wk-form4_1710894461.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,538 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:45 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000228 · wk-form4_1700261139.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,172 Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:56 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 53,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000076 · wf-form4_169231656320810.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,811 F3 · kind: Grant of RSUs that vest in three equal annual installments beginning on August 15, 2024. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 23:56 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 20,771 | $92.99 | $1,931,495.29 |
DisclosureSEC source: 0000721371-23-000076 · wf-form4_169231656320810.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,714 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 41,409 restricted share units ("RSUs") and 38,282 performance share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 21:12 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000192 · wk-form4_1692306750.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,643 Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 23:38 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 38,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000044 · wf-form4_169153791366200.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,485 F1 · kind: Reflects performance share units that will settle on August 15, 2023. Read SEC document |
| May 15, 2023 Filed May 17, 2023 13:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 3,037 | $84.77 | $257,446.49 |
DisclosureSEC source: 0000721371-23-000029 · wf-form4_168432914039495.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,203 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,810 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| May 15, 2023 Filed May 17, 2023 21:39 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 516 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000140 · wk-form4_1684359534.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,168 Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:41 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-23-000056 · wf-form4_167908925450212.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652 Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:30 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 677 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000183 · wf-form4_166863778262511.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994 Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 23:24 UTC | DAVITA INC. DVA · Entity 3482 | GrantCommon Stock | 317 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-22-000146 · wf-form4_166069226617233.xml · nonDerivative · entry 1 Hollar Jason M. · CIK 0001687858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317 Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 20:37 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 8,206 | $69.32 | $568,839.92 |
DisclosureSEC source: 0000721371-22-000089 · wf-form4_166076863855368.xml · nonDerivative · entry 2 Hollar Jason M. · CIK 0001687858 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,240 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 13,302 RSUs and 18,999 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.